These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 19650861

  • 21. Green tea polyphenol (-)-epigallocatechin gallate reduces matrix metalloproteinase-9 activity following transient focal cerebral ischemia.
    Park JW, Hong JS, Lee KS, Kim HY, Lee JJ, Lee SR.
    J Nutr Biochem; 2010 Nov; 21(11):1038-44. PubMed ID: 19962294
    [Abstract] [Full Text] [Related]

  • 22. Green tea polyphenol EGCG suppresses cigarette smoke condensate-induced NF-kappaB activation in normal human bronchial epithelial cells.
    Syed DN, Afaq F, Kweon MH, Hadi N, Bhatia N, Spiegelman VS, Mukhtar H.
    Oncogene; 2007 Feb 01; 26(5):673-82. PubMed ID: 16862172
    [Abstract] [Full Text] [Related]

  • 23. Tumor gelatinases and invasion inhibited by the green tea flavanol epigallocatechin-3-gallate.
    Garbisa S, Sartor L, Biggin S, Salvato B, Benelli R, Albini A.
    Cancer; 2001 Feb 15; 91(4):822-32. PubMed ID: 11241252
    [Abstract] [Full Text] [Related]

  • 24. The epigallocatechin gallate derivative Y6 inhibits human hepatocellular carcinoma by inhibiting angiogenesis in MAPK/ERK1/2 and PI3K/AKT/ HIF-1α/VEGF dependent pathways.
    Liao ZH, Zhu HQ, Chen YY, Chen RL, Fu LX, Li L, Zhou H, Zhou JL, Liang G.
    J Ethnopharmacol; 2020 Sep 15; 259():112852. PubMed ID: 32278759
    [Abstract] [Full Text] [Related]

  • 25. Epigallocatechin-3-gallate inhibits stem-like inflammatory breast cancer cells.
    Mineva ND, Paulson KE, Naber SP, Yee AS, Sonenshein GE.
    PLoS One; 2013 Sep 15; 8(9):e73464. PubMed ID: 24039951
    [Abstract] [Full Text] [Related]

  • 26. Epigallocatechin-3-gallate, a green-tea polyphenol, suppresses Rho signaling in TWNT-4 human hepatic stellate cells.
    Higashi N, Kohjima M, Fukushima M, Ohta S, Kotoh K, Enjoji M, Kobayashi N, Nakamuta M.
    J Lab Clin Med; 2005 Jun 15; 145(6):316-22. PubMed ID: 15976760
    [Abstract] [Full Text] [Related]

  • 27. Green tea catechin inhibits ephrin-A1-mediated cell migration and angiogenesis of human umbilical vein endothelial cells.
    Tang FY, Chiang EP, Shih CJ.
    J Nutr Biochem; 2007 Jun 15; 18(6):391-9. PubMed ID: 17049832
    [Abstract] [Full Text] [Related]

  • 28. Green tea polyphenols: biology and therapeutic implications in cancer.
    Shankar S, Ganapathy S, Srivastava RK.
    Front Biosci; 2007 Sep 01; 12():4881-99. PubMed ID: 17569617
    [Abstract] [Full Text] [Related]

  • 29. Epigalloccatechin-3-gallate inhibits ocular neovascularization and vascular permeability in human retinal pigment epithelial and human retinal microvascular endothelial cells via suppression of MMP-9 and VEGF activation.
    Lee HS, Jun JH, Jung EH, Koo BA, Kim YS.
    Molecules; 2014 Aug 13; 19(8):12150-72. PubMed ID: 25123184
    [Abstract] [Full Text] [Related]

  • 30. Epigallocatechin-3-gallate inhibits the invasion of human oral cancer cells and decreases the productions of matrix metalloproteinases and urokinase-plasminogen activator.
    Ho YC, Yang SF, Peng CY, Chou MY, Chang YC.
    J Oral Pathol Med; 2007 Nov 13; 36(10):588-93. PubMed ID: 17944751
    [Abstract] [Full Text] [Related]

  • 31. Inhibitory effect of green tea polyphenols on membrane-type 1 matrix metalloproteinase, MT1-MMP.
    Oku N, Matsukawa M, Yamakawa S, Asai T, Yahara S, Hashimoto F, Akizawa T.
    Biol Pharm Bull; 2003 Sep 13; 26(9):1235-8. PubMed ID: 12951464
    [Abstract] [Full Text] [Related]

  • 32. Mechanistic aspects of green tea as a cancer preventive: effect of components on human stomach cancer cell lines.
    Okabe S, Ochiai Y, Aida M, Park K, Kim SJ, Nomura T, Suganuma M, Fujiki H.
    Jpn J Cancer Res; 1999 Jul 13; 90(7):733-9. PubMed ID: 10470285
    [Abstract] [Full Text] [Related]

  • 33. Green tea polyphenol epigallocatechin-3-gallate blocks PDGF-induced proliferation and migration of rat pancreatic stellate cells.
    Masamune A, Kikuta K, Satoh M, Suzuki N, Shimosegawa T.
    World J Gastroenterol; 2005 Jun 14; 11(22):3368-74. PubMed ID: 15948241
    [Abstract] [Full Text] [Related]

  • 34. Epigallocatechin-3-gallate inhibits epidermal growth factor receptor signaling pathway. Evidence for direct inhibition of ERK1/2 and AKT kinases.
    Sah JF, Balasubramanian S, Eckert RL, Rorke EA.
    J Biol Chem; 2004 Mar 26; 279(13):12755-62. PubMed ID: 14701854
    [Abstract] [Full Text] [Related]

  • 35. Epigallocatechin-3-gallate inhibits photocarcinogenesis through inhibition of angiogenic factors and activation of CD8+ T cells in tumors.
    Mantena SK, Roy AM, Katiyar SK.
    Photochem Photobiol; 2005 Mar 26; 81(5):1174-9. PubMed ID: 15938647
    [Abstract] [Full Text] [Related]

  • 36. Green tea polyphenol epigallocatechin-3-gallate (EGCG) differentially inhibits interleukin-1 beta-induced expression of matrix metalloproteinase-1 and -13 in human chondrocytes.
    Ahmed S, Wang N, Lalonde M, Goldberg VM, Haqqi TM.
    J Pharmacol Exp Ther; 2004 Feb 26; 308(2):767-73. PubMed ID: 14600251
    [Abstract] [Full Text] [Related]

  • 37. Green tea polyphenol (-)-epigallocatechin 3-gallate inhibits MMP-2 secretion and MT1-MMP-driven migration in glioblastoma cells.
    Annabi B, Lachambre MP, Bousquet-Gagnon N, Page M, Gingras D, Beliveau R.
    Biochim Biophys Acta; 2002 Jan 30; 1542(1-3):209-20. PubMed ID: 11853893
    [Abstract] [Full Text] [Related]

  • 38. Molecular basis for cancer chemoprevention by green tea polyphenol EGCG.
    Tachibana H.
    Forum Nutr; 2009 Jan 30; 61():156-169. PubMed ID: 19367120
    [Abstract] [Full Text] [Related]

  • 39. Gene expression changes induced by green tea polyphenol (-)-epigallocatechin-3-gallate in human bronchial epithelial 21BES cells analyzed by DNA microarray.
    Vittal R, Selvanayagam ZE, Sun Y, Hong J, Liu F, Chin KV, Yang CS.
    Mol Cancer Ther; 2004 Sep 30; 3(9):1091-9. PubMed ID: 15367703
    [Abstract] [Full Text] [Related]

  • 40. A prodrug of green tea polyphenol (-)-epigallocatechin-3-gallate (Pro-EGCG) serves as a novel angiogenesis inhibitor in endometrial cancer.
    Wang J, Man GCW, Chan TH, Kwong J, Wang CC.
    Cancer Lett; 2018 Jan 01; 412():10-20. PubMed ID: 29024813
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.